Stream Biomedical, Inc. Announces Acceptance of Abstract for Presentation at Annual Meeting of the American Society of Neurotherapeutics (ASENT) Conference 2025

HOUSTON, March 4, 2025 /PRNewswire/ — Stream Biomedical, Inc. (“Stream”), a clinical-stage biotechnology company developing novel solutions for acute and chronic neurodegenerative diseases, today announced acceptance of an abstract for presentation at the Annual Meeting of the American…